Application 076896
- Type
- ANDA
- Sponsor
- CHARTWELL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 250MG BASE | No | No |
| 002 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 500MG BASE | No | No |
| 003 | CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 750MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62135-308 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |
| 62135-308 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |
| 62135-309 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |
| 62135-309 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |
| 62135-310 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |
| 62135-310 | Ciprofloxacin | Ciprofloxacin hydrochloride | Chartwell RX, LLC. | ANDA | Current |